Hemostasis Today

March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Shiny K Kajal: Therapeutic Apheresis Is Redefining the Clinical Scope of Transfusion Medicine
Mar 3, 2026, 17:04

Shiny K Kajal: Therapeutic Apheresis Is Redefining the Clinical Scope of Transfusion Medicine

Shiny K Kajal, Senior Resident at Adesh University, shared a post on LinkedIn:

“Post 29 – When most people think of transfusion medicine, they think of blood bags and compatibility testing.

But modern Immunohematology and Blood Transfusion goes far beyond that.

Therapeutic Apheresis allows selective removal of disease-causing components directly from circulation – offering rapid clinical benefit in several critical conditions.

Key Apheresis Modalities

  • Therapeutic Plasma Exchange (TPE) – Removal of pathogenic plasma components
  • Red Cell Exchange – Replacement of abnormal erythrocytes
  • Leukapheresis – Rapid cytoreduction in leukocytosis
  • Plateletpheresis – Control of extreme thrombocytosis
  • LDL Apheresis – Removal of atherogenic lipoproteins

From autoimmune diseases to hematologic emergencies, therapeutic apheresis is redefining the clinical scope of transfusion medicine.

Not just transfusing blood — but therapeutically transforming it.”

Shiny K Kajal

Stay updated with Hemostasis Today.